Startseite Medizin Waist-to-height ratio as a marker of low-grade inflammation in obese children and adolescents
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Waist-to-height ratio as a marker of low-grade inflammation in obese children and adolescents

  • Carolina Caminiti EMAIL logo , Marisa Armeno und Carmen S. Mazza
Veröffentlicht/Copyright: 17. Februar 2016

Abstract

Background: The epidemic of childhood obesity is associated with early atherosclerosis. Several reports have related this event to low-grade inflammation described in obesity. CRP and IL6 are markers that correlate with adiposity. The waist-to-height ratio (WtHR) is an anthropometric marker associated with insulin resistance and inflammation. The objective of this study was to assess the correlation between WtHR, metabolic complications and pro-inflammatory factors in obese children and adolescents.

Methods: Weight, height, waist circumference, glycemia, insulin, CRP, TNF-α and IL-6 were measured in the baseline sample in 280 patients 6–19 years of age with overweight or obesity (OW/OB) and 112 normal-weight controls. Logistic regression was performed using WtHR as an independent variable. p>0.05 STATA11.

Results: Mean WtHR was 0.6±0.06 in OW/OB and 0.43±0.02 in controls (p<0.01). WtHR was increased in 93% of the OW/OB vs. 2% of the controls. In the OW/OB inflammatory markers were significantly increased (p<0.01) compared to the controls (CRP 2.2 vs. 0.8; Il-6 2.9 vs. 2.1; and TNF-α 6.2 vs. 5.5). In the WtHR>0.5, insulin resistence and inflammatory markers were significantly increased (p<0.01) compared to the WtHR<0.5 (HOMA 3.4 vs. 1.4; CRP 2.3 vs. 0.6; Il-6 2.9 vs. 2.1; and TNF-α 6.4 vs. 5.55). In logistic regression, a significant independent association was found between WtHR with CRP (OR1.47), IL6 (OR1.60) and TNF-α (OR1.79).

Conclusions: Obese children and adolescents have high inflammatory markers that may increase cardiovascular risk. WtHR is associated with low-grade inflammation and may be considered a relevant anthropometric marker in the clinical practice.


Corresponding author: Carolina Caminiti, Hospital J. P. Garrahan, Nutrition Department, Combate de los Pozos 1881, CP1245 CABA, Buenos Aires, Argentina, E-mail:

References

1. WHO. Obesity: preventing and managing the global epidemic. WHO: Geneva, Switzerland, Report of a WHO consultation. Report No: 894. 2000.Suche in Google Scholar

2. World Health Organization. Global strategy for non-communicable disease prevention and control (draft). Geneva, Switzerland: World Health Organization, 1997. (Publication no. WHO/NCD/GS/97.1).Suche in Google Scholar

3. Khan BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000;106:473–81.10.1172/JCI10842Suche in Google Scholar

4. Klein S, Burke LE, Bray GA. Clinical implications of obesity with specific focus on cardiovascular disease, a statement for professionals from the American Heart Association Council of Nutrition, Physical Activity, and Metabolism endorsed by the American College of Cardiology foundation. Circulation 2004;110:2952–67.10.1161/01.CIR.0000145546.97738.1ESuche in Google Scholar

5. Atkinson RL. Guidelines for the initiation of obesity treatment. J Nutr Biochem 1998;9:546–52.10.1016/S0955-2863(98)00033-3Suche in Google Scholar

6. Flynn MA, Mc Neil DA, Maloff B. Reducing obesity and related chronic disease risk in children and youth, a synthesis of evidence with best practice recommendations. Obes Rev 2006;7:7–66.10.1111/j.1467-789X.2006.00242.xSuche in Google Scholar PubMed

7. Caballero E, Bousquet-Santos K, Robles-Osorio L, Montagnani V, Soodini G, et al. Overweight latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance. Diabetes Care 2008;31:576–82.10.2337/dc07-1540Suche in Google Scholar PubMed

8. Dowd JB, Zajacova A, Aiello A. Predictors of inflammation in US children aged 3–16 years. Am J Prev Med 2010;39:314–20.10.1016/j.amepre.2010.05.014Suche in Google Scholar PubMed PubMed Central

9. Skinner AC, Steiner MJ, Henderson FW, Perrin EM. Multiple markers of inflammation and weight status: cross sectional analyses throughout childhood. Pediatrics 2010;125: e801–9.10.1542/peds.2009-2182Suche in Google Scholar PubMed PubMed Central

10. Norris AL, Steinberger J, Steffen LM, Metzig AM, Schwarzenberg SJ, et al. Circulating oxidized LDL and inflammation in extreme pediatric obesity. Obesity 2011;19:1415–9.10.1038/oby.2011.21Suche in Google Scholar PubMed PubMed Central

11. Oliver SR, Sosa JS, Milne GL, Pontello AM, Borntrager HL, et al. Increased oxidative stress and altered substrate metabolism in obese children. Int J Pediatr Obes 2010;5:436–44.10.3109/17477160903545163Suche in Google Scholar PubMed PubMed Central

12. Sniger K, Eng DS, Lumeng CN, Cebremariam A, Lee JM. The relationship between body fat mass percentiles and inflammation in children. Obesity (Silver Spring) 2014;22:1332–6.10.1002/oby.20710Suche in Google Scholar PubMed PubMed Central

13. Jarvisalo MJ, Harmoinen A,Hakanen M, Paakkunainen U, Viikari J, et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscl Throm Vasc Biol 2002;22:1323–8.10.1161/01.ATV.0000024222.06463.21Suche in Google Scholar PubMed

14. Qi L, Zhang C, van Dam RM, Hu FB. Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals. J Clin Endocrinol Metab 2007;92:3618–25.10.1210/jc.2007-0877Suche in Google Scholar PubMed

15. Roth CL, Kratz M, Ralston M, Reinehr T. Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children. Metabolism 2011;60:445–52.10.1016/j.metabol.2010.03.023Suche in Google Scholar PubMed

16. Kristiansen OP, Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes 2005;54(Suppl 2): S114–24.10.2337/diabetes.54.suppl_2.S114Suche in Google Scholar

17. Carey AL, Steinberg GR, Macaulay SL, Thomas WG, Holmes AG, et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 2006;55: 2688–97.10.2337/db05-1404Suche in Google Scholar PubMed

18. Qi L, van Dam RM, Meigs JB, Manson JE, Hunter D, et al. Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis. Hum Mol Genet 2006;15:1914–20.10.1093/hmg/ddl113Suche in Google Scholar PubMed

19. Marsland AL, McCaffery JM, Muldoon MF, Manuck SB. Systemic inflammation and the metabolic syndrome among middle-aged community volunteers. Metabolism 2010;59:1801–8.10.1016/j.metabol.2010.05.015Suche in Google Scholar PubMed PubMed Central

20. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87–91.10.1126/science.7678183Suche in Google Scholar PubMed

21. Khoury M, Manlhiot C, McCrindle BW. Role of the waist/height ratio in the cardiometabolic risk assessment of children classified by body mass index. J Am Coll Cardiol 2013;62:742–51.10.1016/j.jacc.2013.01.026Suche in Google Scholar PubMed

22. Mokha JS, Srinivasan SR, Dasmahapatra P, Fernandez C, Chen W, et al. Utility of waist-to-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: the Bogalusa Heart Study. BMC Pediatr 2010;10:73.10.1186/1471-2431-10-73Suche in Google Scholar PubMed PubMed Central

23. Freedman DS, Kahn HS, Mei Z, Grummer-strawn LM, Dietz WH, et al. Relation of body mass index and waist to height ratio to cardiovascular disease risk factors in children and adolescents: the Bogalusa Heart Study. Int J Clin Nutr 2007;86: 33–40.10.1093/ajcn/86.1.33Suche in Google Scholar PubMed

24. Carvalho Vidigal F, Daez de Lima Rosado LE, Paixao Rosado G, de Cassia Lanes Ribeiro R, do Camo Castro, et al. Predictive ability of the anthropometric and body composition indicators for detecting changes in inflammatory markers. Nutr Hosp 2013;28:1639–45.Suche in Google Scholar

25. Olza J, Aguilera CM, Gil-Campos M, Leis R, Buneo G, et al. Waist-to-height-ratio, inflammation and CVD risk in obese children. Public Health Nutr 2014;17:2378–85.10.1017/S1368980013003285Suche in Google Scholar PubMed

26. Guías para la evaluación del crecimiento fisico. Comité Nacional de Crecimiento y Desarrollo. Sociedad Argentina de Pediatría 2013.Suche in Google Scholar

27. National high blood pressure education program working group on high blood pressure in children and adolescents. The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555.10.1542/peds.114.S2.555Suche in Google Scholar

28. Taylor RW, Jones IE, Williams SM,Goulding A. Evaluation of waist circumference, waist-to-hip ratio, and the conicity index as screening tools for high trunk fat mass, as measured by dual-energy X-ray absorptiometry, in children aged 3–19 y. Am J Clin Nutr 2000;72:490–5.10.1093/ajcn/72.2.490Suche in Google Scholar PubMed

29. Update on the task force (1987) on high blood pressure in children and adolescents: a working group from the National High Blood Pressure Education Program. Pediatrics 1996;98:649–58.10.1542/peds.98.4.649Suche in Google Scholar

30. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13–23.10.1136/adc.45.239.13Suche in Google Scholar PubMed PubMed Central

31. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291–303.10.1136/adc.44.235.291Suche in Google Scholar PubMed PubMed Central

32. Haffner S, Miettinen H, Stern M. The homeostasis model in the san antonio heart study. Diabetes Care 1997;20:1087–92.10.2337/diacare.20.7.1087Suche in Google Scholar PubMed

33. Reaven GM, Chen YD, Hollenbeck CB, Sheu WH, Ostrega D, et al. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 1993;76:44–8.Suche in Google Scholar

34. Guntsche Z, Guntsche EM, Saravi FD, Gonzalez LM, Lopez Avellaneda C, et al. Umbilical waist-to-hight ratio and trunk fat mass index (DXA) as markers of central adiposity and insulin resistance in Argentinean children with a family history of metabolic syndrome. J Pediatr Endocrinol Metab 2010;23:245–56.10.1515/JPEM.2010.23.3.245Suche in Google Scholar

35. August G, Caprio S, Fennoy I, Freemark M, Kaufman F, et al. Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin endocrinol Metab 2008;93:4576–99.10.1210/jc.2007-2458Suche in Google Scholar PubMed PubMed Central

36. Magnussen C, Koskinen J, Chen W, Thomson R, Schmidt M, et al. Pediatric metabolic syndrome predicts adulthood metabolic syndrome, suclinical atherosclerosis, and type 2 diabetes mellitus – but is no bettr than body mass index alone: the Bogalusa Heart Study and the cardiovascular risk in young finns study. Circulation 2010;122:1604–11.10.1161/CIRCULATIONAHA.110.940809Suche in Google Scholar

37. Craig ME, Jefferies C, Dabelea D, Balde N, Seth A, et al. Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes 2014;15:(Suppl 20):4–17.10.1111/pedi.12186Suche in Google Scholar

38. Viikari JS, Raitakari OT, Simell O. Nutritional influences on lipids and future atherosclerosis beginning prenatally and during childhood. Curr Opin Lipidol 2002;13:11–8.10.1097/00041433-200202000-00003Suche in Google Scholar

39. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006;83:461–5.10.1093/ajcn/83.2.461SSuche in Google Scholar

40. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004;25:4–7.10.1016/j.it.2003.10.013Suche in Google Scholar

41. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821–30.10.1172/JCI200319451Suche in Google Scholar

42. Das UN. Is obesity an inflammatory condition? Nutrition 2001;17:953–66.10.1016/S0899-9007(01)00672-4Suche in Google Scholar

43. Trayhurn P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005;33:1078–81.10.1042/BST0331078Suche in Google Scholar PubMed

44. Taylor R, Williams SM, Grant AM, Ferguson E, Taylor BJ, et al. Waist circumference as a measure of trunk fat mass in children aged 3 to 5 years. Int J Ped Obes 2008;3:226–33.10.1080/17477160802030429Suche in Google Scholar PubMed

45. Johnson ST, Kuk JL, Mackenzie KA, Huang T, Rosychuk RJ, et al. Metabolic risk varies according to waist circumference measurement site in overweight boys and girls. J Pediatr 2010;156:247–52.10.1016/j.jpeds.2009.08.010Suche in Google Scholar PubMed

46. González Jiménez E, Aguilar Cordero MJ, García López PA, Schmidt Río-Valle J, García García CJ. Analysis of the nutritional state and body composition of school children in Granada (Spain). Nutr Hosp 2012;27:1496–504.Suche in Google Scholar

47. Savva SC, Lamnisos D, Kapatos AG. Predicting cardiometabolic risk: waist to height ratio or BMI. A meta-analysis. Diabetes Metab Syndr Obes 2013;6:403–19.10.2147/DMSO.S34220Suche in Google Scholar PubMed PubMed Central

48. Mazza CS, Ozuna B, Krochik AG, Araujo MB. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in obese Argentinean children and adolescents. J Pediatr Endocrinol Metab 2005;18:491–8.10.1515/JPEM.2005.18.5.491Suche in Google Scholar PubMed

49. Armeno ML, Krochik AG, Mazza CS. Evaluation of two dietary treatments in obese hyperinsulinemic adolescents. J Pediatr Endocrinol Metab 2011;24:715–22.10.1515/JPEM.2011.291Suche in Google Scholar

50. Reyes M, Gahagan S, Diaz E, Blanco E, Leiva L, et al. Relationship of adiposity and insulin resistance mediated by inflammation in a group of overweight and obese Chilean adolescents. Nutrition J 2011;10:4.10.1186/1475-2891-10-4Suche in Google Scholar PubMed PubMed Central

51. Person TA, Mensah GA, Alexander RW, Anderson JL, Cannon PO, et al. Markers of inflammation and cardiovascular disease, application to clinical and public health practice, a statement for healthcare professionals for the Center of Disease Control and Prevention and the American Health Association. Circulation 2003;107:499–511.10.1161/01.CIR.0000052939.59093.45Suche in Google Scholar PubMed

52. Festa A, D’Agostino R Jr, Howard G, Mykkanen L, Tracy RP, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome, the insulin resistance atherosclerosis study (IRAS). Circulation 2000;102:42–7.10.1161/01.CIR.102.1.42Suche in Google Scholar

53. Mc Laughlin T, Abbasi F, Lamendola C, Liang L, Reaven G, et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 2002;106: 2908–12.10.1161/01.CIR.0000041046.32962.86Suche in Google Scholar PubMed

54. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, et al. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 2002;277:1531–7.10.1074/jbc.M101521200Suche in Google Scholar PubMed

55. Prins JB, Nielser CU, Winterford CM, Bright NA, Siddle K, et al. Tumor necrosis factor-alpha induces apoptosis of human adipose cells. Diabetes 1997;46:1939–44.10.2337/diabetes.46.12.1939Suche in Google Scholar

56. Mauras N, Delgiorno C, Kollman C, Bird K, Morgan M, et al. Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J Clin Endocr Metab 2010;95:1060–8.10.1210/jc.2009-1887Suche in Google Scholar PubMed

57. Aygun AD, Gungor S, Ustundag B, Gurgoze MK, Sen Y. Proinflammatory cytokines and leptin are increased in serum of prepubertal obese children. Mediators Inflamm 2005;3: 180–3.10.1155/MI.2005.180Suche in Google Scholar PubMed PubMed Central

58. Bacha F, Gungor N, Lee S, Arslanian SA. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes? Diabetes Care 2009;32:100–5.10.2337/dc08-1030Suche in Google Scholar PubMed PubMed Central

59. Hermsdorff HH, Zulet MA, Puchau B, Martinez A. Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation 2011;34:3.10.1007/s10753-010-9219-ySuche in Google Scholar PubMed

60. González M, del Mar Bibiloni M, Pons A, Llompart I, Tur JA. Inflammatory markers and metabolic syndrome among adolescents. Eur J Clin Nutr 2012;66:1141–5.10.1038/ejcn.2012.112Suche in Google Scholar PubMed

61. Del Mar Bibiloni M, Maffeis C, Llompart I, Pons A, Tur JA. Dietary factors associated with subclinical inflammation among girls. Eur J Clin Nutr. 2013;67:1264–70.10.1038/ejcn.2013.196Suche in Google Scholar PubMed

62. Stelzer I, Zelzer S, Raggam RB, Prüller F, Truschnig-Wilders M, et al. Link between leptin and interleukin-6 levels in the initial phase of obesity related inflammation. Transl Res 2012;159:118–24.10.1016/j.trsl.2011.10.001Suche in Google Scholar PubMed

63. Pirkola J,Vaarasmaki M, Ala-Korpela M, Bloigu A, Canoy D, et al. Low grade, systemic inflammation in adolescents: association with early-life factors, gender and lifestyle. Am J Epidemiol 2010;171:72–82.10.1093/aje/kwp320Suche in Google Scholar PubMed

64. Jung C, Fisher N, Fritzenwagner M, Figulla HR. Anthropometric indices as predictors of the metabolic syndrome and its components in adolescents. Ped Inter 2010;52: 402–9.10.1111/j.1442-200X.2009.02973.xSuche in Google Scholar PubMed

Received: 2015-10-26
Accepted: 2015-12-7
Published Online: 2016-2-17
Published in Print: 2016-5-1

©2016 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Review
  3. Resistance to thyroid hormone α, revelation of basic study to clinical consequences
  4. Original Articles
  5. Improved molecular diagnosis of patients with neonatal diabetes using a combined next-generation sequencing and MS-MLPA approach
  6. Safety and metabolic impact of Ramadan fasting in children and adolescents with type 1 diabetes
  7. Waist-to-height ratio as a marker of low-grade inflammation in obese children and adolescents
  8. Classification and clinical characterization of metabolically “healthy” obese children and adolescents
  9. Long-term BH4 (sapropterin) treatment of children with hyperphenylalaninemia – effect on median Phe/Tyr ratios
  10. Compound heterozygous mutations (p.T561M and c.2422delT) in the TPO gene associated with congenital hypothyroidism
  11. Prevalence and clinical features of polycystic ovarian syndrome in adolescents with previous childhood growth hormone deficiency
  12. Urate crystals deposition in the feet of overweight juveniles and those with symptomatic hyperuricemia: a dual-energy CT study
  13. A novel ALMS1 homozygous mutation in two Turkish brothers with Alström syndrome
  14. Novel AVPR2 mutation causing partial nephrogenic diabetes insipidus in a Japanese family
  15. Pituitary gigantism: a retrospective case series
  16. Case Reports
  17. A novel OTX2 gene frameshift mutation in a child with microphthalmia, ectopic pituitary and growth hormone deficiency
  18. A novel nonsense mutation in the WFS1 gene causes the Wolfram syndrome
  19. A 33-year-old male patient with paternal derived duplication of 14q11.2–14q22.1~22.3: clinical course, phenotypic and genotypic findings
  20. Familial Turner syndrome: the importance of information
  21. De novo mutation of PHEX in a type 1 diabetes patient
  22. Congenital hypothyroidism and thyroid dyshormonogenesis: a case report of siblings with a newly identified mutation in thyroperoxidase
Heruntergeladen am 18.1.2026 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0526/html?lang=de
Button zum nach oben scrollen